Damage to Brain Network Curbs Urge to Smoke

A study finds that injuries to certain areas of the brain were associated with quitting smoking more quickly, easily, and with no cravings.

| 2 min read
stubbed-out cigarette with smoke rising from ashes

© ISTOCK.COM, pcess609

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A study of people who effortlessly quit smoking after a stroke or other brain injury—and of those who suffered an injury but then kept smoking—has pinpointed a brain network involved in addiction, researchers reported June 13 in Nature Medicine. Experts say the findings may help identify targets for therapies that could treat addictions.

“I think this could be one of the most influential publications not only of the year, but of the decade,” A. Thomas McLellan, a professor emeritus of psychiatry at the University of Pennsylvania who also served as deputy director of the US Office of National Drug Control Policy, tells The New York Times. “It puts to rest so many of the stereotypes that still pervade the field of addiction: that addiction is bad parenting, addiction is weak personality, addiction is a lack of morality.” McLellan was not involved in the current research.

In the study, researchers compared the brain scans of 34 people who suddenly quit smoking following a focal brain injury, such as from a stroke, with those of 69 people who continued smoking after such an injury. Study coauthor Juho Joutsa of the University of Turku in Finland tells New Scientist that those who quit had damage to either the dorsal cingulate, the lateral prefrontal cortex, the insula, or to regions that were strongly connected to one of these areas via nerves. Together, these areas seem to comprise an addiction circuit, he tells the magazine. Looking at a separate cohort of 186 patients, the researchers also found that damage to this circuit was associated with a lower likelihood of alcohol addiction, indicating that the circuit may be implicated in addiction generally.

The results suggest that targeting the medial prefrontal cortex, a brain area that tamps down activity in the identified circuit, with transcranial magnetic stimulation might be a promising treatment avenue, Joutsa tells New Scientist. “What we’re realizing across many different fields is that our therapeutic targets are not brain regions, as we once thought, but connected brain circuits,” study coauthor Michael Fox of Harvard Medical School tells the Times. “If you take into account the way the brain is connected, you can improve treatment.”

But some experts tell the Times that there could be challenges to a brain stimulation-based approach, including figuring out which frequency of magnetic stimulation to use, the possibility that treatments would need to be individually tailored, and the challenge of making treatments consistently accessible to people with addictions.

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
iStock: Ifongdesign

The Advent of Automated and AI-Driven Benchwork

sampled
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

Sapio Sciences

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

DeNovix Logo

New DeNovix Helium Nano Volume Spectrophotometer

Olink Logo

Olink® Reveal: Accessible NGS-based proteomics for every lab

Olink logo
Zymo Logo

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit